Drug Trial Radar · NCT05667506
A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)
Last checked: Nov 19, 2026Latest source record: Aug 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
47
Planned (sponsor's estimate)
Start
Feb 7, 2023
Primary completion
May 30, 2025
Study completion May 30, 2027
Sponsor
- Lead sponsor
- Juventas Cell Therapy Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 28, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 3 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, phase Ib/II trial to evaluate the safety and efficacy of CNCT19 treatment in Children and Adolescent (pediatric) patients with relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-cell ALL).
Conditions
- B-cell Acute Lymphoblastic Leukemia
Interventions
single dose of CNCT19Biological
Autologous 2nd generation CD19-directed CAR-T cells, single infusion intravenously. Lymphodepletion treatment: Drugs:Fludarabine Drugs: Cyclophosphamide
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Remission Rate (ORR)Time frame: within 3 months
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
The Second Hospital of Anhui Medical University
Hefei, Anhui, China · Not yet recruiting
Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China · Recruiting
Guangzhou Women and Children's Medical Center
Guangzhou, Guangdong, China · Recruiting
Nanfang Hospital
Guangzhou, Guangdong, China · Not yet recruiting
Union Hospital Tongji Medical College Huazhong University of Science of Technology
Wuhan, Hubei, China · Not yet recruiting
Children's Hospital of Nanjing Medical University
Nanjing, Jiangsu, China · Recruiting
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China · Recruiting
The First Affilicated Hospital of Nanchang University
Nanchang, Jiangxi, China · Recruiting
Institute of Hematology & Blood Diseases Hospital
Tianjin, Tianjin Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.